Business, energy, technology, markets and global industry news from Business News Today

mRNA therapeutics

PharmaDeviceNews mRNA therapeutics
Representative image: A scientist reviews sequencing-style quality control data in a modern biopharma lab, illustrating how Oxford Nanopore Technologies and Lonza aim to improve GMP mRNA testing, release workflows and advanced therapy manufacturing.
Pharma & Biotech

Can Oxford Nanopore and Lonza fix the mRNA quality control bottleneck?

Find out how Oxford Nanopore and Lonza’s GMP mRNA QC solution could simplify release testing for next-generation RNA medicines.

Read More
Pharma & Biotech

Can China Medical University Hospital, Ever Supreme and SHINE OUT BIO reshape spinal cord injury repair?

New exosome therapy targets spinal cord injury repair non-invasively. Find out how this breakthrough could reshape neuroregenerative medicine.

Read More